SCHEMBL960382

SCHEMBL960382

C=CC12CC3CC(CC(C3)C1)C2

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN2D O15399 5/20 0.38
GRIN3B O60391 5/20 0.38
GRIN1 Q05586 5/20 0.38
GRIN2A Q12879 5/20 0.38
GRIN2B Q13224 5/20 0.38
GRIN2C Q14957 5/20 0.38
GRIN3A Q8TCU5 5/20 0.38
LMNA P02545 2/20 0.38
SLC22A2 O15244 2/20 0.38
SLC47A1 Q96FL8 2/20 0.38
SLC22A1 O15245 1/20 0.38
TSHR P16473 1/20 0.38
NFKB1 P19838 1/20 0.38
STAT6 P42226 1/20 0.38
SIGMAR1 Q99720 1/20 0.38
NPFFR1 Q9GZQ6 1/20 0.38
NPFFR2 Q9Y5X5 1/20 0.38
THRB P10828 2/20 0.36
POLB P06746 1/20 0.36
BLM P54132 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Water SCHEMBL4022360 0.97 NPFFR1 (0.37) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
Bicarbonate SCHEMBL20943642 0.87 THRB (0.43) TSHRNPFFR1NPFFR2THRBCYP2C9
SCHEMBL5495240 0.82 MEN1 (0.32) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL6395459 0.80 SIGMAR1 (0.32) SIGMAR1
SCHEMBL4437737 0.78 NPFFR1 (0.31) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL8160229 0.78
SCHEMBL3415057 0.77 NPFFR1 (0.35) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL6348665 0.77 EPHX2 (0.43) TSHR
SCHEMBL3848004 0.77 LMNA (0.32) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL4102744 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 161 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113248455-A 3, 5-disubstituted isoxazole derivatives and synthesis method thereof 湖北科技学院 2021-08-13 CN claimed
US-20080090913-A1 Sphingolipid-Derived Phamaceutical Compositions JADO TECHNOLOGIES GMBH (DE) 2008-04-17 US claimed
US-5053568-A Synthesizing low molecular weight, high viscosity thickening agent, coordination or lewis acid catalyst MOBIL OIL CORP. (US) 1991-10-01 US claimed
JP-4330947-A None JP disclosed
WO-2026101739-A1 CYCLIC SULFONATE COMPOUNDS AS PHOTOACID GENERATORS IN RESIST APPLICATIONS HERAEUS EPURIO LLC (US) 2026-05-15 WO disclosed
US-20250313657-A1 Furan Moiety-Containing Olefin Copolymer and Reversible Crosslinked or Functionalized Olefin Copolymer EXXONMOBIL TECHNOLOGY & ENGINEERING COMPANY (US) 2025-10-09 US disclosed
WO-2025079368-A1 THERMALLY LATENT CATIONIC POLYMERIZATION INITIATOR, CURABLE RESIN COMPOSITION, AND METAL BONDED BODY 株式会社日本触媒 2025-04-17 WO disclosed
CN-118388713-A Preparation method and application of monodentate phosphine and bidentate/multidentate phosphine ligand copolymer 深圳职业技术大学 2024-07-26 CN disclosed
EP-3689981-B1 ACTINIC-RAY-CURABLE INK-JET INK, LIGHT-SHIELDING FILM, AND PRODUCTION METHOD FOR LIGHT-SHIELDING FILM FUJIFILM CORP (JP) 2024-07-10 EP disclosed
US-11945888-B2 Solution polymerization process and product control using effluent density EXXONMOBIL CHEMICAL PATENTS INC. (US) 2024-04-02 US disclosed
US-20230257496-A1 PHOTOCURABLE COMPOSITION INCLUDING A NON-REACTIVE POLYMER CANON KABUSHIKI KAISHA (JP) 2023-08-17 US disclosed
JP-H04330947-A CATALYST FOR PRODUCING 1-VINYL ADAMANTANE AND PRODUCTION OF 1-VINYL ADAMANTANE USING THE SAME KAWASAKI STEEL CORP 1992-11-18 JP disclosed
US-5053568-A Synthesizing low molecular weight, high viscosity thickening agent, coordination or lewis acid catalyst MOBIL OIL CORP. (US) 1991-10-01 US disclosed
US-5053568-A Synthesizing low molecular weight, high viscosity thickening agent, coordination or lewis acid catalyst MOBIL OIL CORP. (US) 1991-10-01 US disclosed
US-5053568-A Synthesizing low molecular weight, high viscosity thickening agent, coordination or lewis acid catalyst MOBIL OIL CORP. (US) 1991-10-01 US disclosed
US-5041403-A Magnesium, titanium, halogen, ester compound, and organic aluminum compound SHOWA DENKO K.K. (JP) 1991-08-20 US disclosed
EP-0383346-A2 Catalyst, process for its preparation and process for polymerization of olefins using this catalyst SHOWA DENKO KABUSHIKI KAISHA (JP) 1990-08-22 EP disclosed
EP-0155551-B1 METHOD FOR THE PARTIAL HYDROGENATION OF CONJUGATED DIENES MITSUBISHI KASEI CORPORATION (JP) 1988-07-06 EP disclosed
US-4590319-A USING AS CATALYST A COBALT COMPOUND, ORGANOPHOSPHINE COMPOUND, AND ALUMINUM COMPOUND MITSUBISHI CHEMICAL INDUSTRIES, LTD. (JP) 1986-05-20 US disclosed
EP-0155551-A1 Method for the partial hydrogenation of conjugated dienes MITSUBISHI KASEI CORPORATION (JP) 1985-09-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080090913-A1 Sphingolipid-Derived Phamaceutical Compositions SGMS1, SGMS2, SMPD2 GRIN2D 3040/4885GRIN3B 2084/4885GRIN1 2204/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.